Tag: Insurance: Medicare
Heterogeneity Found in Appropriate Use Criteria for Imaging of CAD
CMS-qualified AUC for coronary artery disease heterogeneous, sometimes conflict with respect to appropriateness
Medicare Will Cover New Class of Alzheimer Drugs if Fully Approved by FDA, With...
Drug makers will also have to gather and keep data in a registry showing how the drugs are working in the real world
Medication for Opioid Use Disorder Dispensed More After Medicare Policy Change
Methadone dispensing up after 2020 without displacing use of buprenorphine
Medicare Spending Would Increase $2.0 to $5.1 Billion With Lecanemab
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Other Countries Rate Half of Top-Selling Drugs in Medicare as Low Added Benefit
These low added therapeutic-rating drugs accounted for $19.3 billion or one-third of Medicare annual net spending in 2020
Psychiatrist Reimbursement Lower With Medicaid Than Medicare
State-to-national Medicaid indices for psychiatrists' mental health services varied from 0.46 to 2.34 in Pennsylvania and Nebraska, respectively
Biden Administration Calls for Crackdown on Misleading Medicare Ads
New rule would ban ads that have confusing words, imagery, or logos, or that do not specifically mention a health insurance plan by name
Medicare Eligibility Linked to Improvements in Health Care Access
For low-income adults, Medicare eligibility linked to reduction in percentage delaying or avoiding medical care due to cost
Peritoneal Dialysis Less Costly for Medicare Than Hemodialysis
Convergence in the costs of intravenous dialysis drugs seen between peritoneal dialysis, hemodialysis
How Will New Federal Legislation Cut Drug Costs?
Under the law, Medicare will now be allowed to negotiate the cost of some drugs; vaccines will be free for Part D recipients